Article ID: 707682 Sophisticated Blood Analysis Provides New Clues About Ebola, Treatment AvenuesPacific Northwest National LaboratoryA detailed analysis of blood samples from Ebola patients is providing clues about the progression of the effects of the virus in patients and potential treatment pathways. The findings point to a critical role for a molecular pathway that relies on the common nutrient choline, as well as the importance of cellular bodies known as microvesicles. Released:6-Feb-2019 5:15 PM EST |
Article ID: 707067 NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children'sCincinnati Children's Hospital Medical CenterA Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) has begun in the United States at Cincinnati Children’s Hospital Medical Center. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). Released:28-Jan-2019 9:05 AM ESTChannels: Infectious Diseases, Vaccines, Ebola, Pharmaceuticals, Local - Ohio Ebola, virus, infectious diseases, National Institute of , Ebola, Vaccine, Infectious Diseases, National Institute Of Allergy And Infectious Diseases, National Institues Of Health, Cincinnati Children's Hospital Medical Center, Vaccine and Treatment Evaluation Unit (VTEU), Africa, Ebola outbreak, Research, clinical trial, Clinical Trials, clinical tri |
Article ID: 706582 Another Piece of Ebola Virus Puzzle IdentifiedTexas Biomedical Research InstituteA team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. Scientists at Texas Biomedical Research Institute were part of a nationwide collaborative with scientists at Gladstone Institutes, UC San Francisco and Georgia State University for a study recently published in the journal Cell. Released:17-Jan-2019 10:00 AM EST |
![]() Article ID: 705407 Ebola-Fighting Protein Discovered in Human CellsNorthwestern UniversityEbola virus (green) infects human cells much more easily when you remove the protective RBBP6 protein (compare left to right). Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new study from Northwestern University, Georgia State University, University of California, San Francisco (UCSF) and the Gladstone Institutes published today, Dec. Released:13-Dec-2018 11:05 AM EST |
Article ID: 702339 Texas Biomed Scientists Researching Ebola-Malaria ConnectionTexas Biomedical Research InstituteTexas Biomed researchers – in collaboration with the University of Iowa – are trying to find out how malarial infections impact people exposed to Ebola virus. Both diseases are endemic in that region. Released:17-Oct-2018 11:00 AM EDT |
Released:16-Oct-2018 4:05 AM EDTChannels: Infectious Diseases, Ebola, Healthcare, Public Health, Local - DC, Local - DC Metro |
![]()
Article ID: 701959 Synthetic DNA Vaccine Against Ebola Virus Shows Potent and Long-term Efficacy in Preclinical StudiesWistar InstituteA novel synthetic DNA vaccine developed based on technology pioneered by Wistar scientists offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical research. Released:10-Oct-2018 9:10 AM EDT |
Article ID: 701256 Text Messages Quickly Track Health Care Use During Ebola OutbreakNew York UniversityA new study from the NYU College of Global Public Health and NYU Tandon School of Engineering, published in Nature Digital Medicine, used text message surveys to determine in real time how people used maternal health services during a recent Ebola outbreak and measured a drop in hospital-based births during the outbreak. Released:27-Sep-2018 1:05 PM EDT |
Article ID: 700447 Rare Antibodies Show Scientists How to Neutralize the Many Types of EbolaScripps Research InstituteTwo new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not only for Ebola virus, but for other closely related pathogens as well. Released:12-Sep-2018 4:45 PM EDT |
Article ID: 699544 As Ebola outbreak spreads, a research team introduces new questions with the discovery of first known virus transmission from female survivorNorthern Arizona UniversityGeneticist Jason Ladner talks about the study, which underscores the need for focused prevention efforts among survivors and better capacity to detect new cases of the deadly virus. Released:24-Aug-2018 6:05 PM EDTChannels: All Journal News, Infectious Diseases, Ebola Ebola, Genetics, The Lancet Infectious Diseaes, Centers for Disease Control and Prevention (CDC), World Health Organisation, U.S. Army Medical Research Institute of Infectious Diseases, National Institiutes Of Health, International Rescue Committee, West Africa |